Pfizer begins study of Covid jabs updated to match Omicron variant

(Yui Mok/PA)
(Yui Mok/PA)

Pfizer has begun a study comparing its original Covid-19 vaccine with doses specially tweaked to match the hugely contagious Omicron variant.

Pfizer and its partner BioNTech announced the study on Tuesday.

You have reached your article limit. Already a subscriber? Sign in

Clubber TV and Irish Examiner logos in offer banner

Every Match. Every Story.

One Ultimate Bundle

No obligation. Ts&Cs apply.

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited